| Annual and Long Service Leave Guidelines
|
SESLHDGL/067 |
|
| Annual Leave and Excessive Annual Leave (EAL) Management
|
SESLHDPR/436 |
|
| Authority to use the NSW Government Waratah and SESLHD Logo
|
SESLHDPR/227 |
|
| Laser Safety - managing the hazards
|
SESLHDPR/162 |
|
| Learning and Development Leave Procedure
|
SESLHDPR/430 |
|
| Leech Therapy
|
SESLHDGL/035 |
|
| Legislative Compliance Framework
|
SESLHDHB/025 |
|
| Linagliptin for Type 2 Diabetes Prescribing Protocol
|
SESLHDPR/644 |
|
| Lorazepam intramuscular injection for the acute management of aggressive and agitated behaviour of patients in Mental Health Inpatient Units
|
SESLHDPR/592 |
|
| Lumbar Puncture - Adult
|
SESLHDPR/613 |
|
| Sick Leave Management
|
SESLHDPR/412 |
|
| Sterilisation: Reusable Medical Devices (RMDs) on Loan
|
SESLHDPR/249 |
|
| Subcutaneous levetiracetam for seizure management in palliative care patients
|
SESLHDPR/692 |
|
| Subcutaneous levomepromazine for refractory nausea in the palliative care patient and agitation in the terminal phase
|
SESLHDPR/693 |
|
| Subcutaneous lidocaine (lignocaine) for refractory neuropathic pain in the palliative care setting
|
SESLHDPR/694 |
|
| Work Health and Safety - Lift Entrapment Procedures Development Guideline
|
SESLHDGL/028 |
|
